Blue‐Purple evaluation: Chromoproteins facilitate the identification of BioBrick compatibility
Biotechnology and Bioengineering · 2025-01 · 122 (1) · 233-241
DOI: 10.1002/bit.28862 ↗At a glance
Journal article in Biotechnology and Bioengineering, published online on 2024-10-14. Written by Fang Ba and 4 co-authors. Institution: School of Physical Science and Technology, ShanghaiTech University, Shanghai, China. Major MEDLINE topics: Escherichia coli, Synthetic Biology. Cited 2 times so far (Crossref); 26 references. Funded by: National Key Research and Development Program of China 2023YFA0914000, National Natural Science Foundation of China 32171427, National Natural Science Foundation of China.
Abstract (original language)
Synthetic BioBricks introduce novel capabilities to manipulate genetic information, direct transcription‐translation processes, and program cellular behaviors in living organisms. To maintain the stability and functionality of synthetic BioBricks, assembled DNA fragments should be mutually compatible without inducing negative effects such as metabolic burden or cellular toxicity in host cells. However, a simple, rapid, and reliable method to evaluate BioBrick compatibility remains to be developed. In this study, we report BP (Blue/Purple, Ban/Pick) evaluation, a method utilizing chromoproteins to facilitate the identification of BioBrick compatibility in one‐pot reactions. By visualizing and quantifying the ratio of blue to purple Escherichia coli ( E. coli ) colonies on LB‐agar plates, we can easily validate the compatibility of desired BioBrick constructions. To demonstrate our design, we characterized BioBrick assemblies with antitoxin‐toxin pair ccdA‐ccdB, lysis protein E, or heterologous protein sfGFP. Among these, we successfully identified several compatible assemblies. We anticipate that BP evaluation will enhance biotechnological assessments of BioBrick compatibility in vivo and expand the application of chromoproteins in synthetic biology.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- School of Physical Science and Technology, ShanghaiTech University, Shanghai, China.
- State Key Laboratory of Advanced Medical Materials and Devices, ShanghaiTech University, Shanghai, China.
- Shanghai Clinical Research and Trial Center, Shanghai, China.
Funding
- National Key Research and Development Program of China 2023YFA0914000
- National Natural Science Foundation of China 32171427
- National Natural Science Foundation of China
Cite
APA
Ba, F., Zhang, Y., Wang, L., Liu, W. Q., & Li, J. (2025). Blue‐Purple evaluation: Chromoproteins facilitate the identification of BioBrick compatibility. Biotechnology and Bioengineering, 122(1), 233-241. https://doi.org/10.1002/bit.28862
Vancouver
Ba F, Zhang Y, Wang L, Liu WQ, Li J. Blue‐Purple evaluation: Chromoproteins facilitate the identification of BioBrick compatibility. Biotechnology and Bioengineering. 2025;122(1):233-241. doi:10.1002/bit.28862
BibTeX
@article{Ba2025,
author = {Ba, Fang and Zhang, Yufei and Wang, Luyao and Liu, Wan-Qiu and Li, Jian},
title = {Blue‐Purple evaluation: Chromoproteins facilitate the identification of BioBrick compatibility},
journal = {Biotechnology and Bioengineering},
year = {2025},
volume = {122},
number = {1},
pages = {233--241},
doi = {10.1002/bit.28862}
}
EUVIMED